PSP Research »

Disc Medicine shares owned by PSP Research

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $512k 8.0k 63.94

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Disc Medicine

FMR
RA Capital Management
BlackRock
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
Vanguard Capital Management
Frazier Life Sciences Management
TCG Crossover Management
BVF
State Street Corporation
OrbiMed Advisors
Siren
Woodline Partners
Geode Capital Management

View all funds holding Disc Medicine